Tranexamic acid as initial treatment for unresectable metastatic colorectal cancer

ABSTRACT: Interventions: Off-label use Primary outcome(s): Progression-free Survival:PFS Study Design: randomized controlled trial, open(masking not used), active control, parallel assignment, treatment purpose

DISEASE(S): Metastatic Colorectal Cancer

PROVIDER: 2614207 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR